Sector Update: Healthcare Stocks Rise in Afternoon Trading
MT newswire2026/10/07 17:4601:46 PM EDT, 10/07/2026 (MT Newswires) -- Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index adding 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) advancing 1.7%. The iShares Biotechnology ETF (IBB) increased 0.8%. In sector news, Alphabet's (GOOGL) Google DeepMind, Meta (META), and Isomorphic Labs are collectively investing $300 million in Biohub's Virtual Biology Initiative to build datasets for AI models to predict and treat diseases, Biohub said Wednesday. In corporate news, Halozyme Therapeutics (HALO) shares rose 1.9% after the company said it has been awarded an injunction by the specialized Dutch patent court in The Hague that stops manufacture and sale of Merck's (MRK) Keytruda SC in multiple European markets. Merck shares were up 0.9%. Novartis (NVS) shares rose 2% after the firm said the US Food and Drug Administration has approved Rhapsido for adults with symptomatic dermographism inadequately controlled by H1 antihistamines. Pfizer (PFE) plans to cut about 330 jobs at its Sicily plant in Italy, Reuters reported Wednesday, citing labor unions. The plant employs about 550 people, the report said. Shares rose 2.2%. Ultragenyx Pharmaceutical (RARE) shares added 2.7% after the firm said Wednesday it has agreed to sell a rare pediatric disease priority review voucher for $210 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Survival period doubled! AstraZeneca's new stomach cancer drug Sone-ve aims for $5 billion in annual sales, ADC takes another step towards replacing chemotherapy
AstraZeneca's gastric cancer ADC doubles patient survival, extending life by five more months, aiming for annual sales of $5 billion; the company is racing with Takeda and Astellas to target Claudin 18.2.
16 trillion Korean won "big dividend"! SK hynix (SKHY.US) plans to distribute 80% of Kioxia stake earnings generously to shareholders
According to reports, SK Hynix plans to return about 80% of the proceeds from reducing its stake in Japan's Kioxia Holdings to shareholders by distributing a special dividend of approximately 16 trillion won (about $12 billion).
Korean retail investors start bottom fishing! Their targets are still "Samsung and SK Hynix leveraged ETFs"
Amid a sharp drop in Korean stocks, Korean retail investors turned contrarian, making a net purchase of over 315.4 billion KRW in leveraged products of Samsung and SK Hynix in October alone. They simultaneously spent 4.7 trillion KRW acquiring US-listed triple-leveraged semiconductor ETF (SOXL), accounting for nearly 74% of total purchases of US stocks during the same period. This marks the first rebound since tightening regulations in July and two consecutive months of net selling.
AI Bubble Index at 74, CoreWeave (CRWV.US) stock price may fall below $50
CoreWeave's stock price has dropped nearly 70% from its peak to $54.25, with the short interest ratio rising to 15%. As the AI bubble index reaches an extreme value of 74 and the company faces $3 billion in debt pressure, its share price is at risk of falling below the critical support level of $50.
Crypto prices
More
